113 related articles for article (PubMed ID: 22085577)
1. [Issues around testicular carcinoma].
Nuver J; Oosting SF; Gietema JA
Ned Tijdschr Geneeskd; 2011; 155(45):A4092. PubMed ID: 22085577
[TBL] [Abstract][Full Text] [Related]
2. [A patient with bilateral testicular cancer].
Dijkstra SS; Witjes JA
Ned Tijdschr Geneeskd; 2012; 156(11):A3392. PubMed ID: 22414668
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
4. [Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].
van Veelen LR; Steyerberg EW; Cleton FJ; Keizer HJ
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):564-8. PubMed ID: 10321275
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the treatment of testicular cancer.
Huddart RA; Birtle AJ
Expert Rev Anticancer Ther; 2005 Feb; 5(1):123-38. PubMed ID: 15757445
[TBL] [Abstract][Full Text] [Related]
6. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of testicular cancer.
Embil JM; Weinerman BH; Pascoe EA
Can J Surg; 1994 Apr; 37(2):165-7. PubMed ID: 8156473
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in clinical therapeutics: testicular cancer.
Bergmann KA
Clin Pharm; 1987 Sep; 6(9):693-706. PubMed ID: 2445518
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of testicular cancer].
Witjes JA; Debruyne FM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):557-60. PubMed ID: 10321273
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
13. Long-term chemotherapy-related cardiovascular morbidity.
Meinardi MT; Gietema JA; van Veldhuisen DJ; van der Graaf WT; de Vries EG; Sleijfer DT
Cancer Treat Rev; 2000 Dec; 26(6):429-47. PubMed ID: 11139373
[TBL] [Abstract][Full Text] [Related]
14. [The current therapeutic strategy in testicular cancer].
Miron L
Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):29-39. PubMed ID: 9455346
[TBL] [Abstract][Full Text] [Related]
15. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
16. Testicular cancer patients: considerations in long-term follow-up.
Gospodarowicz M
Hematol Oncol Clin North Am; 2008 Apr; 22(2):245-55, vi. PubMed ID: 18395148
[TBL] [Abstract][Full Text] [Related]
17. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.
Skoogh J; Steineck G; Stierner U; Cavallin-Ståhl E; Wilderäng U; Wallin A; Gatz M; Johansson B;
Acta Oncol; 2012 Feb; 51(2):185-97. PubMed ID: 21851186
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, vinblastine and bleocin in the treatment of disseminated testicular cancer.
Koynov KD; Tzekova VI; Velikova MT
Int Urol Nephrol; 1993; 25(4):389-94. PubMed ID: 7506242
[TBL] [Abstract][Full Text] [Related]
19. Coffee grounds emesis: rare presentation of testicular cancer treated with neoadjuvant chemotherapy.
Thompson JL; Blute ML
Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302504
[TBL] [Abstract][Full Text] [Related]
20. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors.
Gilbert DC; Van As NJ; Huddart RA
Expert Rev Anticancer Ther; 2009 Feb; 9(2):223-33. PubMed ID: 19192960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]